murin
macrophag
cell
line
purchas
atcc
manassa
va
cytochalasin
purchas
mp
biomed
solon
oh
blocker
lipid
transport
purchas
calbiochem
torrey
pine
ca
sodium
cholat
cholesteryl
oleat
fucoidan
chemic
purchas
st
loui
mo
popc
lissamin
rhodamin
b
sulfonyl
rho
b
cholesterol
purchas
avanti
polar
lipid
alabast
al
follow
synthet
peptid
order
bachem
torranc
ca
one
peptid
gflskslvf
human
two
methionin
sulfoxid
peptid
pylddfqkkwqeem
elyrqkv
plgeem
rdrarahvdalrthla
correspond
human
apo
helic
apo
apo
respect
two
methionin
sulfoxid
peptid
gflskslvfpylddfqkkwqeem
elyrqkv
gflskslvfplgeem
rdrarahvdalrthla
lipopeptid
complex
spheric
morpholog
contain
either
equimolar
mixtur
equimolar
mixtur
synthes
use
sodium
cholat
dialysi
procedur
purifi
character
initi
molar
ratio
correspond
popc
cholesterol
cholesteryl
oleat
apo
sodium
cholat
respect
apo
equimolar
mixtur
initi
molar
ratio
correspond
popc
cholesterol
cholesteryl
oleat
sodium
cholat
respect
equimolar
mixtur
quantit
vitro
macrophag
assay
endocytosi
rho
lipopeptid
complex
macrophag
perform
briefli
balbc
murin
macrophag
cell
atcc
cultur
dulbecco
modifi
eagl
medium
cellgro
mediatech
manassa
va
mm
glutamin
uml
penicillin
mgml
streptomycin
fetal
bovin
serum
cellgro
mediatech
grown
approxim
confluenc
tissu
cultur
plate
corn
costar
corn
ny
reach
target
confluenc
cell
incub
hour
medium
without
fucoidan
cytochalasin
cell
subsequ
incub
hour
hour
medium
contain
rho
calcul
rho
b
cell
wash
twice
use
salin
lyse
use
passiv
lysi
buffer
promega
madison
wi
rho
b
fluoresc
measur
lysat
excit
emiss
filter
use
fluoroscan
ascent
cf
fluoresc
micropl
reader
thermo
labsystem
vantaa
finland
protein
concentr
lysat
measur
use
bradford
reagent
mrx
micropl
reader
dynex
technolog
chantilli
va
accord
manufactur
recommend
protocol
femal
mice
purchas
jackson
laboratori
bar
harbor
hous
univers
massachusett
medic
school
umm
anim
facil
anim
receiv
human
care
accord
protocol
approv
umm
institut
anim
use
care
committe
mice
n
acclim
liquid
diet
ethanol
etoh
volum
vol
vol
period
week
maintain
diet
week
pf
control
mice
fed
diet
anim
unrestrict
access
water
throughout
entir
experiment
period
treat
group
mice
intraperiton
treat
daysweek
vehicl
empti
hdl
inhibitori
formul
mg
mg
equival
signablok
shrewsburi
first
day
etoh
diet
end
anim
experi
cheek
blood
sampl
collect
serum
collect
tube
bd
bioscienc
san
jose
ca
process
within
hour
blood
collect
mice
euthan
liver
sampl
harvest
store
analysi
total
protein
extract
liver
sampl
use
radio
immunoprecipit
assay
buffer
boston
bioproduct
supplement
proteas
inhibitor
cocktail
tablet
roch
phospho
stop
phosphatas
inhibitor
roch
cell
debri
remov
cell
lysat
minut
centrifug
rpm
serum
alt
level
determin
kinet
method
use
commerci
avail
reagent
teco
diagnost
anaheim
ca
cytokin
level
measur
serum
sampl
lysat
dilut
assay
diluent
follow
manufactur
instruct
specif
immunosorb
assay
elisa
kit
use
quantif
biolegend
inc
san
diego
ca
r
system
minneapoli
mn
level
normal
total
protein
concentr
lysat
determin
use
pierc
bicinchonin
acid
protein
assay
protein
boil
laemmli
buffer
sampl
resolv
sodium
dodecyl
gel
electrophoresi
gel
reduc
condit
use
buffer
system
resolv
protein
transfer
onto
nitrocellulos
membran
syk
protein
detect
specif
primari
antibodi
syk
cell
signal
abcam
follow
appropri
secondari
horseradish
immunoglobulin
g
antibodi
santa
cruz
biotechnolog
detect
antibodi
abcam
use
load
control
specif
immunoreact
band
interest
visual
chemiluminesc
laboratori
use
fujifilm
luminesc
imag
analyz
total
rna
extract
use
qiagen
rneasi
kit
qiagen
accord
manufactur
instruct
deoxyribonucleas
treatment
rna
quantifi
use
nanodrop
spectrophotomet
thermo
fisher
scientif
complementari
dna
synthesi
perform
use
iscript
revers
transcript
supermix
laboratori
total
rna
quantit
polymeras
chain
reaction
pcr
perform
use
itaq
univers
sybr
green
supermix
detect
system
laboratori
rel
gene
express
calcul
compar
method
express
level
target
gene
normal
housekeep
gene
ribosom
rna
sampl
fold
chang
target
gene
express
among
experiment
group
express
ratio
primer
synthes
idt
inc
sequenc
list
tabl
section
liver
specimen
mice
stain
hematoxylin
eosin
h
e
thermo
fisher
scientif
mpo
abcam
antibodi
immunohistochemistri
ihc
sampl
stain
oil
red
umm
diabet
endocrinolog
research
center
histolog
core
facil
statist
analys
perform
use
graphpad
prism
graphpad
softwar
inc
signific
level
determin
use
analysi
varianc
follow
test
multipl
comparison
data
shown
mean
sem
differ
consid
statist
signific
p
previou
report
show
activ
lead
express
releas
proinflammatori
cytokin
chemokin
nuclear
factor
activ
also
regul
express
provid
posit
feedback
loop
express
proinflammatori
cytokin
express
increas
therefor
hypothes
signal
contribut
amplif
proinflammatori
pathway
ald
evalu
hypothesi
first
test
mrna
pf
mice
without
treatment
two
differ
inhibitori
formul
vehicl
control
alcohol
administr
model
ald
found
mrna
level
significantli
increas
liver
mice
compar
pf
control
fig
b
contrast
mice
treat
inhibitor
inhibit
chang
addit
mrna
level
correspond
pf
control
fig
b
although
induct
mice
reach
statist
signific
compar
pf
control
blockad
result
signific
inhibit
mrna
mice
compar
vehicl
treatment
fig
mrna
express
also
significantli
attenu
formul
well
pf
group
fig
mrna
level
increas
mice
blockad
significantli
attenu
increas
compar
vehicl
control
fig
regul
activ
normal
cell
express
secret
rant
mrna
level
chang
regardless
alcohol
feed
treatment
fig
f
next
use
specif
elisa
kit
assess
protein
level
cytokin
serum
lysat
fig
found
signific
increas
level
serum
liver
liver
mice
compar
pf
control
fig
increas
prevent
serum
liver
administr
either
inhibitor
interestingli
found
attenu
liver
induct
even
hdl
group
fig
increas
total
level
alcohol
feed
attenu
inhibit
reach
statist
signific
fig
molecul
trigger
syk
activ
one
proxim
signal
molecul
previous
found
increas
syk
phosphoryl
liver
test
level
total
activ
liver
found
significantli
increas
total
level
alcohol
feed
fig
treatment
significantli
decreas
level
mice
compar
untreat
group
decreas
level
compar
group
fig
f
agreement
previou
studi
indic
chronic
alcohol
use
caus
hepat
macrophag
infiltr
found
increas
express
kupffer
cellmacrophag
marker
mrna
level
treatment
inhibitor
significantli
attenu
express
liver
indic
effect
fig
b
also
found
signific
decreas
express
liver
section
ihc
mice
treat
either
compar
group
fig
neutrophil
infiltr
liver
characterist
alcohol
hepat
therefor
investig
marker
associ
cell
popul
express
neutrophil
marker
mpo
significantli
increas
liver
mice
compar
pf
control
fulli
prevent
blockad
fig
f
interestingli
hdl
vehicl
alon
also
result
decreas
trend
mpo
express
mice
howev
inhibitor
significantli
attenu
mpo
level
even
compar
mice
fig
f
mpo
stain
ihc
confirm
inhibitor
significantli
reduc
cell
number
compar
untreat
control
group
fig
h
next
evalu
impact
inhibitor
hepatocyt
damag
steatosi
liver
serum
alt
level
obtain
week
alcohol
feed
show
signific
increas
mice
compar
pf
control
alt
increas
attenu
group
indic
attenu
liver
injuri
fig
interestingli
vehicl
treatment
hdl
also
show
similar
protect
effect
fig
consist
steatosi
found
signific
increas
oil
red
stain
liver
mice
compar
pf
control
fig
oil
red
fig
h
e
fig
stain
reveal
attenu
steatosi
mice
compar
untreat
vehicl
hdl
group
fig
assess
effect
inhibitor
mechan
lipid
metabol
test
gene
involv
lipid
synthesi
sterol
regulatori
element
bind
transcript
factor
carboxylas
along
lipid
accumul
marker
adrp
fig
inhibitor
vehicl
treatment
prevent
adrp
mrna
level
fig
assess
lipid
oxid
test
peroxisom
receptor
carnitin
palmitoyl
transferas
dehydrogenas
mcad
mrna
level
sampl
fig
alcohol
feed
significantli
reduc
mrna
express
mcad
decreas
trend
inhibitor
well
vehicl
treatment
significantli
increas
mcad
level
compar
untreat
control
fig
clinic
progress
ald
associ
liver
mous
model
ald
mimic
earli
phase
human
diseas
yet
mrna
level
earli
fibrosi
marker
significantli
increas
mice
compar
pf
control
sampl
fig
b
induct
maker
remark
attenu
group
importantli
decreas
inhibitori
formul
use
fig
b
studi
uptak
vitro
order
evalu
potenti
mechan
target
deliveri
kupffer
cell
recruit
hepat
macrophag
express
high
level
sr
includ
involv
phagocytosi
remov
oxid
damag
lipoprotein
cell
blood
previous
demonstr
intracellular
macrophag
deliveri
respect
hypothes
observ
macrophag
endocytosi
complex
sr
investig
molecular
mechan
involv
process
use
macrophag
model
kupffer
cell
incub
rho
presenc
absenc
cytochalasin
fucoidan
known
inhibit
respect
presenc
cytochalasin
inhibit
macrophag
uptak
inhibitor
complex
significantli
inhibit
suggest
uptak
sr
mediat
fucoidan
inhibitor
substanti
suppress
endocytosi
inhibitor
complex
hour
hour
indic
mechan
endocytosi
fig
contrast
inhibit
similarli
inhibit
uptak
complex
time
point
lesser
extent
compar
fucoidan
fig
presum
lower
express
find
suggest
main
contributor
endocytosi
interestingli
quantit
determin
macrophag
uptak
level
presenc
absenc
fucoidan
similar
fig
importantli
suggest
combin
apo
peptid
sequenc
sequenc
chang
level
mechan
macrophag
endocytosi
compar
studi
report
first
time
import
role
ald
use
mous
model
found
signific
liver
mice
follow
chronic
alcohol
feed
treatment
novel
inhibitor
reduc
express
molecul
attenu
fulli
prevent
increas
proinflammatori
cytokin
mrna
level
inhibit
syk
activ
demonstr
blockad
result
reduc
macrophag
neutrophil
infiltr
activ
indic
reduc
mpo
express
liver
find
complement
previou
data
demonstr
blockad
use
suppress
macrophag
infiltr
tumor
cancer
inhibitor
attenu
liver
steatosi
hdl
inhibitor
also
attenu
liver
injuri
marker
earli
fibrosi
mice
interestingli
hdl
vehicl
control
show
similar
effici
inhibitori
formul
protein
level
proinflammatori
cytokin
discov
hdl
protect
effect
ald
level
alt
lipid
oxid
ligand
still
unknown
shown
activ
amplifi
inflamm
synerg
tlr
signal
also
observ
bacteri
infect
challeng
lp
lipoteicho
acid
increas
indic
posit
feedback
loop
among
pamp
exposur
express
inflammatori
cytokin
induct
differ
damp
group
box
protein
correct
made
octob
correct
protein
note
heat
shock
protein
suggest
stimul
studi
found
cell
granulocyt
platelet
activ
pamp
damp
present
ald
provid
potenti
mechan
diseas
alcohol
induc
chang
gut
microbiom
disrupt
gut
barrier
function
result
increas
level
endotoxin
microbi
pamp
alcohol
also
caus
hepatocyt
damag
lead
releas
process
contribut
activ
signal
lead
phosphoryl
activ
syk
indic
major
regul
inflammatori
process
also
amplifi
signal
involv
downstream
syk
activ
inde
found
increas
total
phosphoryl
syk
level
liver
mice
attenu
inhibitor
administr
previou
studi
show
inhibit
syk
activ
attenu
liver
inflamm
cell
death
steatosi
suggest
syk
pathway
could
feasibl
therapeut
target
syk
express
wild
spectrum
cell
inhibit
may
specif
modul
macrophag
neutrophil
stellat
cell
play
role
ald
anoth
advantag
inhibit
like
attenu
signal
broader
spectrum
tlr
activ
alon
shown
increas
product
proinflammatori
chemokin
furthermor
simultan
stimul
tlr
agonist
antibodi
differ
tlr
ligand
synerg
induct
proinflammatori
molecul
costimul
monocyt
show
increas
product
contrast
level
cytokin
decreas
antibodi
ligand
poli
c
ligand
lp
simultan
attach
proinflammatori
pathway
present
alcohol
hepat
interrupt
pathway
use
inhibit
seem
attract
induc
factor
inhibit
product
involv
activ
recruit
monocyt
modul
inflammatori
furthermor
express
highli
surfac
infiltr
monocyt
neutrophil
human
tissu
infect
bacteria
highlight
import
receptor
alcohol
hepat
neutrophil
infiltr
liver
induc
oxid
stress
cytotox
contribut
high
mortal
show
process
attenu
inhibitor
mechanist
formul
target
liver
effici
peptid
alon
releas
inhibitori
sequenc
insid
target
cell
peptid
like
inhibit
signal
disrupt
intramembran
interact
receptor
signal
adaptor
molecul
dnax
activ
protein
correct
made
octob
correct
protein
note
fig
previous
hypothes
observ
preferenti
endocytosi
macrophag
hepat
clearanc
complex
mediat
sr
recognit
put
epitop
modifi
apo
peptid
constitu
current
find
indic
larg
recogn
macrophag
fig
also
observ
uptak
like
explain
previous
observ
hepat
clearanc
complex
anoth
anim
data
confirm
hypothesi
futur
studi
need
determin
clearanc
properti
ald
present
studi
demonstr
exhibit
similar
macrophag
uptak
vitro
larg
driven
fig
also
similar
therapeut
effect
mous
model
ald
fig
line
previou
studi
exhibit
similar
therapeut
activ
cancer
arthrit
suggest
epitop
similarli
expos
provid
similar
uptak
complex
result
deliveri
inhibitori
peptid
sequenc
vivo
use
develop
effect
therapi
ald
advantag
make
entir
manufactur
process
easier
less
expens
also
suggest
vitro
macrophag
uptak
assay
potenti
use
predict
outcom
therapi
vivo
addit
attenu
inflammatori
process
inhibitori
formul
also
amelior
hepatocyt
damag
steatosi
serum
alt
liver
triglycerid
level
decreas
treat
group
vehicl
also
inhibitori
effect
protein
level
well
mrna
express
neutrophil
fibrosi
marker
indic
hdl
vehicl
formul
attenu
inflamm
moder
extent
previou
studi
found
evid
hdl
protect
hepatocyt
endoplasm
reticulum
public
report
scaveng
function
hdl
lp
lipoteicho
could
prevent
immun
cell
activ
observ
moder
benefici
effect
hdl
treatment
alon
fatti
acid
oxid
marker
mice
fig
line
data
demonstr
infus
reconstitut
hdl
reduc
fatti
acid
oxid
patient
type
diabet
human
rat
plasma
apo
major
protein
hdl
shown
inhibit
lipid
data
might
provid
explan
find
hepatoprotect
effect
hdl
studi
show
inhibitor
hdl
formul
exert
signific
inhibit
earli
signal
event
proinflammatori
process
level
cytokin
mrna
activ
protein
level
compar
hdl
vehicl
alon
mous
model
ald
effect
presum
would
even
obviou
protein
level
cytokin
sever
liver
injuri
howev
mice
commonli
use
alcohol
feed
use
result
moder
liver
damag
minim
limit
studi
importantli
shown
stain
liver
section
formul
significantli
inhibit
immun
cell
infiltr
steatosi
compar
hdl
vehicl
group
correct
made
octob
word
group
ad
mice
ald
thu
explor
inhibitor
decreas
inflamm
deserv
investig
ald
dr
sigalov
dr
shen
employ
signablok
dr
szabo
hepatolog
commun
fulli
excus
peer
review
manuscript
